I-Dengue NS1 Antigen, I-IgM/IgG Antibody Dual
Igama lomkhiqizo
I-HWTS-FE031-Dengue NS1 Antigen, I-IgM/IgG Antibody Dual Detection Kit (Immunochromatography)
Isitifiketi
CE
I-Epidemiology
I-Dengue fever yisifo esithathelwanayo esiyingozi esibangelwa ukulunywa omiyane besifazane abaphethe i-dengue virus (DENV), esithathelwana ngokushesha, izinga eliphezulu, ukuthambekela okusakazekile, nokufa okuphezulu ezimeni ezinzima..
Babalelwa ku-390 million abantu emhlabeni jikelele abangenwa wudenga unyaka nonyaka, kanti bangu-96 million abantu abahaqwe yilesi sifo emazweni angaphezu kuka-120, ikakhulukazi e-Afrika, emazweni aseMelika, eNingizimu-mpumalanga ye-Asia naseWestern Pacific.Njengoba ukufudumala kwembulunga yonke kwanda, imfiva yodenga manje isisakazekela ezindaweni ezipholile nezibandayo nasezindaweni eziphakeme, futhi ukwanda kwama-serotypes kuyashintsha.Eminyakeni yamuva nje, isimo sobhubhane somkhuhlane wodenga sibi kakhulu esifundeni saseNingizimu Pacific, e-Afrika, eNingizimu Melika, eningizimu-mpumalanga ye-Asia naseNingizimu-mpumalanga ye-Asia, futhi sibonisa amazinga ahlukene okwanda ohlotsheni lwawo lwe-serotype yokudlulisela, indawo yokuphakama, izinkathi zonyaka, izinga lokufa kanye inani lezifo.
Imininingwane esemthethweni ye-WHO ngo-Agasti 2019 ikhombise ukuthi bekunamacala angaba ngu-200,000 omkhuhlane wodenga nokufa kwabantu abangama-958 ePhilippines.IMalaysia yayiqongelele abantu abangaphezu kuka-85,000 abantu abaphethwe udenga phakathi no-August 2019, kuyilapho iVietnam yayiqongelele amacala angama-88,000.Uma kuqhathaniswa nesikhathi esifanayo ngo-2018, inani lenyuke ngokuphindwe kabili kuwo womabili la mazwe.I-WHO iye yabheka umkhuhlane wodenga njengenkinga enkulu yezempilo yomphakathi.
Lo mkhiqizo uyikhithi esheshayo, esizeni futhi enembile yokuthola igciwane lodenga i-NS1 antigen kanye ne-IgM/IgG yamasosha omzimba.I-antibody ethile ye-IgM ikhombisa ukuthi kukhona ukutheleleka kwakamuva, kodwa ukuhlolwa kwe-IgM okungenayo akufakazeli ukuthi umzimba awunalo igciwane.Kuyadingeka futhi ukuthola amasosha omzimba athile e-IgG anesigamu sempilo ende kanye nokuqukethwe okuphezulu kakhulu ukuze kuqinisekiswe ukuxilongwa.Ngaphezu kwalokho, ngemva kokuba umzimba usuthelelekile, i-antigen ye-NS1 ivela kuqala, ngakho ukutholakala ngesikhathi esisodwa kwegciwane lodenga i-NS1 antigen kanye namasosha omzimba athile e-IgM kanye ne-IgG kungaxilonga ngempumelelo ukusabela komzimba ku-pathogen ethile, futhi lokhu kuhlonzwa okuhlangene kwe-antigen-antibody. Ikhithi ingakwazi ukuxilonga ngokushesha futhi ihlole esigabeni sokuqala sokutheleleka kodenga, ukutheleleka okuyisisekelo kanye nokutheleleka kwesibili noma okuningi kodenga, ifinyeze isikhathi sewindi futhi ithuthukise izinga lokutholwa.
Imingcele Yezobuchwepheshe
| Isifunda esiqondiwe | Igciwane lodenga i-NS1 antigen, IgM ne-IgG amasosha omzimba |
| Izinga lokushisa lesitoreji | 4℃-30℃ |
| Uhlobo lwesampula | I-serum yomuntu, i-plasma, igazi le-venous kanye negazi leminwe |
| Impilo yeshelufu | Izinyanga ezingu-12 |
| Izinsimbi ezisizayo | Akudingeki |
| Izinto Ezisetshenziswayo Ezengeziwe | Akudingeki |
| Isikhathi sokutholwa | 15-20 amaminithi |
| Ukucaciswa | Yenza ukuhlolwa kwe-cross-reactivity nge-Japanese encephalitis virus, igciwane le-encephalitis yehlathi, i-hemorrhagic fever ene-thrombocytopenia syndrome, i-Xinjiang hemorrhagic fever, i-hantavirus, igciwane le-hepatitis C, igciwane lomkhuhlane A, igciwane lomkhuhlane B, akukho-cross-reactivity etholakalayo. |
Ukugeleza komsebenzi
●Igazi le-venous (i-Serum, i-Plasma, noma Igazi Eliphelele)
●Igazi lomunwe
●Funda umphumela (15-20 imiz)
